gilteritinib in r/r aml
Published 3 years ago • 155 plays • Length 6:24Download video MP4
Download video MP3
Similar videos
-
2:18
multi-dimensional analysis of the mutational landscape of aml
-
4:33
video: the new standard for mutational profiling of oncology samples
-
3:13
preliminary results from the frida study: iadademstat and gilteritinib in flt3-mutated r/r aml
-
2:20
distinguishing between de novo aml and secondary aml using mutational signatures
-
1:21
intensive therapy of older aml
-
3:30
clinical value of event-free survival in aml
-
7:53
5 tips for caregivers of individuals with acute myeloid leukemia (aml)
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
3:30
unmet needs in mf: managing anemia & improving the efficacy of first and second-line treatments
-
2:26
improving outcomes for flt3-mutated r/r aml
-
4:39
aml & mds: mac or ric?
-
2:05
investigating mutation order in aml using single-cell sequencing
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
1:03
personalizing aml treatment by targeting mrd mutations
-
8:34
hct in mds: cell source and conditioning type
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
6:47
the 2021 treatment algorithm for flt3-mutated aml
-
5:01
novel classification system to improve post-transplant aml prognosis
-
2:44
the impact of mutation screening on transplant decisions in mds
-
1:40
mutations in all and their implications for treatment decisions
-
4:37
updates from uk ncri aml18
-
1:49
bringing precision medicine and mrd into clinical strategies